Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs
- 20 April 2007
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 154 (1), 70-81
- https://doi.org/10.1016/j.molbiopara.2007.04.009
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Malaria control and the evolution of drug resistance: an intriguing linkTrends in Parasitology, 2003
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Drugs to Combat Tropical Protozoan ParasitesScience, 2002
- Targeting critical regions in genomic DNA with AT-specific anticancer drugsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Clinical status and implications of antimalarial drug resistanceMicrobes and Infection, 2002
- Progress and challenges for malaria vaccinesNature, 2002
- Emerging targets for antimalarial drugsEmerging Therapeutic Targets, 2001
- Antimalarial activity of synthetic analogues of distamycinPharmacology & Therapeutics, 1997
- Selective toxicity to malaria parasites by non-intercalating DNA-binding ligandsMolecular and Biochemical Parasitology, 1993